Similar articles

• Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials.

  Pratt CM, Greenway PS, Schoenfeld MH, Hibben ML, Reiffel JA. Pratt CM, et al. Circulation. 1996 Feb 1;93(3):519-24. doi: 10.1161/01.cir.93.3.519. Circulation. 1996. PMID: 8565170
• Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation.

  Sandner SE, Wieselthaler G, Zuckermann A, Taghavi S, Schmidinger H, Pacher R, Ploner M, Laufer G, Wolner E, Grimm M. Sandner SE, et al. Circulation. 2001 Sep 18;104(12 Suppl 1):I171-6. doi: 10.1161/hc37t1.094916. Circulation. 2001. PMID: 11568051
• Sudden Death in Patients With Cardiac Implantable Electronic Devices.

  Tseng ZH, Hayward RM, Clark NM, Mulvanny CG, Colburn BJ, Ursell PC, Olgin JE, Hart AP, Moffatt E. Tseng ZH, et al. JAMA Intern Med. 2015 Aug;175(8):1342-50. doi: 10.1001/jamainternmed.2015.2641. JAMA Intern Med. 2015. PMID: 26098676
• Combining electrical therapies for advanced heart failure: the Milan experience with biventricular pacing-defibrillation backup combination for primary prevention of sudden cardiac death.

  Pappone C, Vicedomini G, Augello G, Mazzone P, Nardi S, Rosanio S. Pappone C, et al. Am J Cardiol. 2003 May 8;91(9A):74F-80F. doi: 10.1016/s0002-9149(02)03341-6. Am J Cardiol. 2003. PMID: 12729853 Review.
• Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.

  Das M. Das M. Expert Rev Cardiovasc Ther. 2009 Feb;7(2):181-95. doi: 10.1586/14779072.7.2.181. Expert Rev Cardiovasc Ther. 2009. PMID: 19210214 Review.